A detailed history of Thrivent Financial For Lutherans transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 22,887 shares of ANIK stock, worth $561,189. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,887
Previous 28,340 19.24%
Holding current value
$561,189
Previous $720,000 19.44%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$24.57 - $28.47 $133,980 - $155,246
-5,453 Reduced 19.24%
22,887 $580,000
Q4 2023

Feb 14, 2024

SELL
$18.47 - $23.3 $25,580 - $32,270
-1,385 Reduced 4.66%
28,340 $642,000
Q3 2023

Nov 14, 2023

SELL
$16.98 - $26.1 $239,706 - $368,453
-14,117 Reduced 32.2%
29,725 $554,000
Q2 2023

Aug 14, 2023

BUY
$25.16 - $28.86 $398,861 - $457,517
15,853 Added 56.64%
43,842 $1.14 Million
Q1 2023

May 17, 2023

SELL
$25.91 - $32.1 $193,547 - $239,787
-7,470 Reduced 21.07%
27,989 $804,000
Q4 2022

Feb 08, 2023

BUY
$23.85 - $31.91 $163,539 - $218,806
6,857 Added 23.97%
35,459 $1.05 Million
Q3 2022

Nov 14, 2022

BUY
$21.74 - $24.68 $93,786 - $106,469
4,314 Added 17.76%
28,602 $681,000
Q2 2022

Aug 16, 2022

BUY
$20.4 - $25.53 $255,713 - $320,018
12,535 Added 106.65%
24,288 $542,000
Q1 2022

May 13, 2022

BUY
$24.7 - $36.54 $98 - $146
4 Added 0.03%
11,753 $295,000
Q4 2021

Feb 16, 2022

BUY
$35.83 - $45.03 $3,260 - $4,097
91 Added 0.78%
11,749 $421,000
Q3 2021

Nov 15, 2021

SELL
$38.75 - $44.47 $4,146 - $4,758
-107 Reduced 0.91%
11,658 $496,000
Q2 2021

Aug 19, 2021

SELL
$39.42 - $48.08 $275 - $336
-7 Reduced 0.06%
11,765 $509,000
Q1 2021

May 17, 2021

SELL
$32.49 - $45.96 $259 - $367
-8 Reduced 0.07%
11,772 $480,000
Q3 2020

Nov 10, 2020

SELL
$32.56 - $38.57 $3,483 - $4,126
-107 Reduced 0.9%
11,780 $417,000
Q2 2020

Aug 12, 2020

SELL
$27.83 - $37.73 $2,003 - $2,716
-72 Reduced 0.6%
11,887 $448,000
Q1 2020

May 15, 2020

BUY
$22.38 - $54.06 $13,360 - $32,273
597 Added 5.25%
11,959 $346,000
Q4 2019

Feb 13, 2020

BUY
$51.85 - $73.36 $21,310 - $30,150
411 Added 3.75%
11,362 $589,000
Q3 2019

Nov 14, 2019

SELL
$40.05 - $57.47 $7,929 - $11,379
-198 Reduced 1.78%
10,951 $601,000
Q2 2019

Aug 13, 2019

BUY
$30.3 - $41.14 $9,090 - $12,342
300 Added 2.77%
11,149 $453,000
Q1 2019

May 14, 2019

BUY
$29.37 - $40.49 $9,662 - $13,321
329 Added 3.13%
10,849 $328,000
Q4 2018

Feb 15, 2019

BUY
$30.16 - $43.0 $6,966 - $9,933
231 Added 2.25%
10,520 $354,000
Q3 2018

Nov 15, 2018

BUY
$32.83 - $42.51 $5,712 - $7,396
174 Added 1.72%
10,289 $434,000
Q2 2018

Aug 14, 2018

BUY
$28.77 - $48.27 $18,901 - $31,713
657 Added 6.95%
10,115 $324,000
Q1 2018

May 08, 2018

BUY
$49.22 - $68.43 $16,636 - $23,129
338 Added 3.71%
9,458 $470,000
Q4 2017

Feb 14, 2018

BUY
$52.14 - $59.94 $9,385 - $10,789
180 Added 2.01%
9,120 $492,000
Q3 2017

Nov 14, 2017

BUY
$51.16 - $58.21 $457,370 - $520,397
8,940
8,940 $519,000

Others Institutions Holding ANIK

About Anika Therapeutics, Inc.


  • Ticker ANIK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,599,900
  • Market Cap $358M
  • Description
  • Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...
More about ANIK
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.